Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12596 | 894 | 34.7 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
12596 | 1 | DESIALYLATED LOW DENSITY LIPOPROTEINS//CALCIUM ANTAGONISTS//INTRACELLULAR CHOLESTEROL ACCUMULATION | 894 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DESIALYLATED LOW DENSITY LIPOPROTEINS | authKW | 204926 | 1% | 100% | 6 |
2 | CALCIUM ANTAGONISTS | authKW | 190241 | 11% | 6% | 96 |
3 | INTRACELLULAR CHOLESTEROL ACCUMULATION | authKW | 167352 | 1% | 70% | 7 |
4 | INTERCELLULAR INTERACT | address | 136618 | 0% | 100% | 4 |
5 | LIPOPROTEIN AGGREGATION | authKW | 106729 | 1% | 63% | 5 |
6 | APOLIPOPROTEIN B BOUND CHOLESTEROL | authKW | 102463 | 0% | 100% | 3 |
7 | MECH ATHEROGENESIS | address | 102463 | 0% | 100% | 3 |
8 | LACIDIPINE | authKW | 93574 | 3% | 12% | 23 |
9 | ANTIOXIDANT PHARMACOL | address | 76846 | 0% | 75% | 3 |
10 | NITROSONIFEDIPINE | authKW | 76846 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 7355 | 36% | 0% | 321 |
2 | Peripheral Vascular Diseases | 5852 | 24% | 0% | 215 |
3 | Pharmacology & Pharmacy | 1955 | 29% | 0% | 256 |
4 | Medicine, Research & Experimental | 377 | 9% | 0% | 78 |
5 | Pathology | 116 | 4% | 0% | 35 |
6 | Medical Laboratory Technology | 66 | 2% | 0% | 15 |
7 | Biophysics | 52 | 4% | 0% | 35 |
8 | Anatomy & Morphology | 52 | 1% | 0% | 11 |
9 | Biochemistry & Molecular Biology | 41 | 11% | 0% | 94 |
10 | Cell Biology | 40 | 6% | 0% | 50 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERCELLULAR INTERACT | 136618 | 0% | 100% | 4 |
2 | MECH ATHEROGENESIS | 102463 | 0% | 100% | 3 |
3 | ANTIOXIDANT PHARMACOL | 76846 | 0% | 75% | 3 |
4 | CARDIOLMEMBRANE BIOPHYS | 68309 | 0% | 100% | 2 |
5 | PHYSIOL BIOCHEM SURG | 68309 | 0% | 100% | 2 |
6 | PHYSICOCHEM METHODS STUDY ANAL | 45538 | 0% | 67% | 2 |
7 | AN MYASNIKOV CLIN CARDIOL | 34154 | 0% | 100% | 1 |
8 | ATHEROGENESIS MECH | 34154 | 0% | 100% | 1 |
9 | ATHEROGENESIS MECHANISMS | 34154 | 0% | 100% | 1 |
10 | CARDIOLMINIST HLTH RUSSIAN FEDERAT | 34154 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS | 13557 | 7% | 1% | 65 |
2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 11895 | 7% | 1% | 62 |
3 | ARTERIOSCLEROSIS | 4744 | 1% | 1% | 10 |
4 | ARTERY | 3144 | 1% | 1% | 7 |
5 | CARDIOVASCULAR DRUGS AND THERAPY | 2959 | 1% | 1% | 13 |
6 | HYPERTENSION RESEARCH | 2680 | 2% | 1% | 14 |
7 | BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2621 | 4% | 0% | 32 |
8 | CARDIOVASCULAR DRUG REVIEWS | 2023 | 1% | 1% | 5 |
9 | KARDIOLOGIYA | 1484 | 2% | 0% | 17 |
10 | REVISTA LATINOAMERICANA DE HIPERTENSION | 1390 | 0% | 2% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CATAPANO, AL , (1997) CALCIUM ANTAGONISTS AND ATHEROSCLEROSIS - EXPERIMENTAL EVIDENCE.EUROPEAN HEART JOURNAL. VOL. 18. ISSUE . P. A80-A86 | 48 | 89% | 11 |
2 | MANCINI, GBJ , (2002) ANTIATHEROSCLEROTIC EFFECTS OF CALCIUM CHANNEL BLOCKERS.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 45. ISSUE 1. P. 1-20 | 44 | 61% | 21 |
3 | OREKHOV, AN , IVANOVA, EA , (2016) CELLULAR MODELS OF ATHEROSCLEROSIS AND THEIR IMPLICATION FOR TESTING NATURAL SUBSTANCES WITH ANTI-ATHEROSCLEROTIC POTENTIAL.PHYTOMEDICINE. VOL. 23. ISSUE 11. P. 1190 -1197 | 33 | 48% | 1 |
4 | LECHAT, P , HADJIISKY, P , (1993) CALCIUM-ANTAGONISTS AND ATHEROSCLEROSIS.THERAPIE. VOL. 48. ISSUE . P. 665-670 | 29 | 100% | 1 |
5 | NAITO, M , KUZUYA, F , (1993) EFFECTS OF CALCIUM-ANTAGONISTS AND OTHER ANTIHYPERTENSIVE AGENTS ON EXPERIMENTAL ATHEROSCLEROSIS - A REVIEW.JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. VOL. 15. ISSUE 2. P. 77 -90 | 35 | 81% | 2 |
6 | HOLZGREVE, H , BURKLE, B , (1993) ANTIATHEROSCLEROTIC EFFECTS OF CALCIUM-ANTAGONISTS.JOURNAL OF HYPERTENSION. VOL. 11. ISSUE . P. S55-S59 | 26 | 100% | 11 |
7 | ISHII, N , MATSUMURA, T , SHIMODA, S , ARAKI, E , (2012) ANTI-ATHEROSCLEROTIC POTENTIAL OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS.JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. VOL. 19. ISSUE 8. P. 693 -704 | 40 | 34% | 6 |
8 | OREKHOV, AN , (2013) DIRECT ANTI-ATHEROSCLEROTIC THERAPY; DEVELOPMENT OF NATURAL ANTI-ATHEROSCLEROTIC DRUGS PREVENTING CELLULAR CHOLESTEROL RETENTION.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 33. P. 5909-5928 | 41 | 33% | 3 |
9 | GARCIA-PEREZ, B , AYALA, I , CASTELLS, MT , DOMENECH, G , SANCHEZ-POLO, MT , GARCIA-PARTIDA, P , VALDES, M , (2005) EFFECTS OF NIFEDIPINE, VERAPAMIL AND DILTIAZEM ON SERUM BIOCHEMICAL PARAMETERS AND AORTIC COMPOSITION OF ATHEROSCLEROTIC CHICKENS.BIOMEDICINE & PHARMACOTHERAPY. VOL. 59. ISSUE 1-2. P. 1 -7 | 27 | 61% | 7 |
10 | FREY, M , JUST, H , (1994) ROLE OF CALCIUM-ANTAGONISTS IN PROGRESSION OF ARTERIOSCLEROSIS - EVIDENCE FROM ANIMAL-EXPERIMENTS AND CLINICAL-EXPERIENCE .1. PREVENTIVE EFFECTS OF CALCIUM-ANTAGONISTS IN ANIMAL-EXPERIMENTS.BASIC RESEARCH IN CARDIOLOGY. VOL. 89. ISSUE . P. 161-176 | 27 | 90% | 2 |
Classes with closest relation at Level 1 |